2022
DOI: 10.3389/fonc.2022.1099965
|View full text |Cite
|
Sign up to set email alerts
|

A tumor microenvironment preoperative nomogram for prediction of lymph node metastasis in bladder cancer

Abstract: BackgroundGrowing evidence suggests that tumor metastasis necessitates multi-step microenvironmental regulation. Lymph node metastasis (LNM) influences both pre- and post-operative bladder cancer (BLCA) treatment strategies. Given that current LNM diagnosis methods are still insufficient, we intend to investigate the microenvironmental changes in BLCA with and without LNM and develop a prediction model to confirm LNM status.Method"Estimation of Stromal and Immune cells in Malignant Tumors using Expression data… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…This limitation of technology creates an uncertainty for CLNs akin to Schrodinger's cat, where metastasis is hard to determine before lymph nodes are removed and examined histopathologically. Emerging non‐invasive methods for assessing CLNs primarily include artificial intelligence‐assisted predictive models, 86,87 nanoparticle‐based lymphatic system imaging, 88 and biomarker‐based liquid biopsies 89 . These studies are still in the experimental stage, and their widespread clinical application remains a distant goal.…”
Section: Dilemmas and Prospectsmentioning
confidence: 99%
“…This limitation of technology creates an uncertainty for CLNs akin to Schrodinger's cat, where metastasis is hard to determine before lymph nodes are removed and examined histopathologically. Emerging non‐invasive methods for assessing CLNs primarily include artificial intelligence‐assisted predictive models, 86,87 nanoparticle‐based lymphatic system imaging, 88 and biomarker‐based liquid biopsies 89 . These studies are still in the experimental stage, and their widespread clinical application remains a distant goal.…”
Section: Dilemmas and Prospectsmentioning
confidence: 99%